Literature DB >> 21091637

NAD+ depletion or PAR polymer formation: which plays the role of executioner in ischaemic cell death?

C Siegel1, L D McCullough.   

Abstract

Multiple cell death pathways are activated in cerebral ischaemia. Much of the initial injury, especially in the core of the infarct where cerebral blood flow is severely reduced, is necrotic and secondary to severe energy failure. However, there is considerable evidence that delayed cell death continues for several days, primarily in the penumbral region. As reperfusion therapies grow in number and effectiveness, restoration of blood flow early after injury may lead to a shift towards apoptosis. It is important to elucidate what are the key mediators of apoptotic cell death after stroke, as inhibition of apoptosis may have therapeutic implications. There are two well described pathways that lead to apoptotic cell death; the caspase pathway and the more recently described caspase-independent pathway triggered by poly-ADP-ribose polymers (PARP) activation. Caspase-induced cell death is initiated by release of mitochondrial cytochrome c, formation of the cytosolic apoptosome, and activation of endonucleases leading to a multitude of small randomly cleaved DNA fragments. In contrast caspase-independent cell death is secondary to activation of apoptosis inducing factor (AIF). Mitochondrial AIF translocates to the nucleus, where it induces peripheral chromatin condensation, as well as characteristic high-molecular-weight (50 kbp) DNA fragmentation. Although caspase-independent cell death has been recognized for some time and is known to contribute to ischaemic injury, the upstream triggering events leading to activation of this pathway remain unclear. The two major theories are that ischaemia leads to nicotinamide adenine dinucleotide (NAD+) depletion and subsequent energy failure, or alternatively that cell death is directly triggered by a pro-apoptotic factor produced by activation of the DNA repair enzyme PARP. PARP activation is robust in the ischaemic brain producing variable lengths of poly-ADP-ribose (PAR) polymers as byproducts of PARP activation. PAR polymers may be directly toxic by triggering mitochondrial AIF release independently of NAD+ depletion. Recently, sex differences have been discovered that illustrate the importance of understanding these molecular pathways, especially as new therapeutics targeting apoptotic cell death are developed. Cell death in females proceeds primarily via caspase activation whereas caspase-independent mechanisms triggered by the activation of PARP predominate in the male brain. This review summarizes the current literature in an attempt to clarify the roles of NAD+ and PAR polymers in caspase-independent cell death, and discuss sex specific cell death to provide an example of the possible importance of these downstream mediators.
© 2011 The Authors. Acta Physiologica © 2011 Scandinavian Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21091637      PMCID: PMC3135708          DOI: 10.1111/j.1748-1716.2010.02229.x

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  81 in total

Review 1.  SIRT1 and neuronal diseases.

Authors:  Bor Luen Tang; Christelle En Lin Chua
Journal:  Mol Aspects Med       Date:  2007-02-16

Review 2.  Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases.

Authors:  Shin-Ichiro Imai
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 3.  Sex differences in stroke.

Authors:  L Christine Turtzo; Louise D McCullough
Journal:  Cerebrovasc Dis       Date:  2008-09-23       Impact factor: 2.762

4.  Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by SIRT1 may endanger energetically compromised neurons.

Authors:  Dong Liu; Robert Gharavi; Michael Pitta; Marc Gleichmann; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2009-03-14       Impact factor: 3.843

Review 5.  Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.

Authors:  Pal Pacher; Csaba Szabo
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

Review 6.  Nampt: linking NAD biology, metabolism and cancer.

Authors:  Antje Garten; Stefanie Petzold; Antje Körner; Shin-Ichiro Imai; Wieland Kiess
Journal:  Trends Endocrinol Metab       Date:  2008-12-26       Impact factor: 12.015

Review 7.  Linking sirtuins, IGF-I signaling, and starvation.

Authors:  Valter D Longo
Journal:  Exp Gerontol       Date:  2008-06-24       Impact factor: 4.032

Review 8.  Cellular and molecular neurobiology of brain preconditioning.

Authors:  Jean Lud Cadet; Irina N Krasnova
Journal:  Mol Neurobiol       Date:  2009-01-20       Impact factor: 5.590

Review 9.  Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues.

Authors:  Marcella Fulco; Vittorio Sartorelli
Journal:  Cell Cycle       Date:  2008-12-09       Impact factor: 4.534

Review 10.  Pathways to ischemic neuronal cell death: are sex differences relevant?

Authors:  Jesse T Lang; Louise D McCullough
Journal:  J Transl Med       Date:  2008-06-23       Impact factor: 5.531

View more
  17 in total

Review 1.  Mitochondrial maintenance failure in aging and role of sexual dimorphism.

Authors:  John Tower
Journal:  Arch Biochem Biophys       Date:  2014-10-25       Impact factor: 4.013

2.  Inverse susceptibility to oxidative death of lymphocytes obtained from Alzheimer's patients and skin cancer survivors: increased apoptosis in Alzheimer's and reduced necrosis in cancer.

Authors:  Maria I Behrens; Monica Silva; Felipe Salech; Daniela P Ponce; Daniela Merino; Mariana Sinning; Chengjie Xiong; Catherine M Roe; Andrew F G Quest
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-02-24       Impact factor: 6.053

3.  Poly(ADP-ribose) polymerase-1 inhibition by arsenite promotes the survival of cells with unrepaired DNA lesions induced by UV exposure.

Authors:  Xu-Jun Qin; Wenlan Liu; Ying-Na Li; Xi Sun; Chun-Xu Hai; Laurie G Hudson; Ke Jian Liu
Journal:  Toxicol Sci       Date:  2012-03-02       Impact factor: 4.849

Review 4.  Translating cell survival and cell longevity into treatment strategies with SIRT1.

Authors:  K Maiese; Z Z Chong; Yan Chen Shang; S Wang
Journal:  Rom J Morphol Embryol       Date:  2011       Impact factor: 1.033

5.  A dual role for poly(ADP-ribose) polymerase-1 during caspase-dependent apoptosis.

Authors:  Fengjiao Zhang; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2012-04-20       Impact factor: 4.849

Review 6.  Novel directions for diabetes mellitus drug discovery.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang
Journal:  Expert Opin Drug Discov       Date:  2012-10-24       Impact factor: 6.098

Review 7.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

8.  NAD+ and nicotinamide: sex differences in cerebral ischemia.

Authors:  C S Siegel; L D McCullough
Journal:  Neuroscience       Date:  2013-02-09       Impact factor: 3.590

Review 9.  ARTD1 (PARP1) activation and NAD(+) in DNA repair and cell death.

Authors:  Elise Fouquerel; Robert W Sobol
Journal:  DNA Repair (Amst)       Date:  2014-10-03

10.  Cluster of differentiation 38 (CD38) mediates bile acid-induced acinar cell injury and pancreatitis through cyclic ADP-ribose and intracellular calcium release.

Authors:  Abrahim I Orabi; Kamaldeen A Muili; Tanveer A Javed; Shunqian Jin; Thottala Jayaraman; Frances E Lund; Sohail Z Husain
Journal:  J Biol Chem       Date:  2013-08-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.